Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CRXT

Clarus Therapeutics (CRXT)

Clarus Therapeutics Holdings Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CRXT
DatumZeitQuelleÜberschriftSymbolFirma
07/03/202312h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202313h36Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202313h23Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202313h20Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202313h17Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
01/03/202313h07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:CRXTClarus Therapeutics Holdings Inc
22/02/202322h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
24/01/202322h02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
22/12/202222h24Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
23/11/202212h11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
18/10/202222h05GlobeNewswire Inc.Clarus Therapeutics Holdings, Inc. Announces Completion of Auction for Sale of JATENZO® and Selection of Tolmar, Inc. as Successful BidderNASDAQ:CRXTClarus Therapeutics Holdings Inc
14/09/202215h52Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:CRXTClarus Therapeutics Holdings Inc
06/09/202204h19GlobeNewswire Inc.Clarus Therapeutics Holdings, Inc. Announces Plan for Near-Term Sale of JATENZO® Using Structured Process Through Chapter 11 of the U.S. Bankruptcy CodeNASDAQ:CRXTClarus Therapeutics Holdings Inc
26/08/202222h37Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
26/08/202222h33Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
26/08/202222h30Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
26/08/202222h19Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
22/08/202218h05TipRanksClarus Therapeutics Holdings (CRXT) was downgraded to a Hold Rating at NeedhamNASDAQ:CRXTClarus Therapeutics Holdings Inc
19/08/202212h38Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
19/08/202212h34Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
19/08/202212h32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
19/08/202212h13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CRXTClarus Therapeutics Holdings Inc
18/08/202222h50Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
18/08/202222h14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
18/08/202222h05GlobeNewswire Inc.Clarus Therapeutics Reports Second Quarter 2022 Financial and Operating Results and Announces Workforce ReductionNASDAQ:CRXTClarus Therapeutics Holdings Inc
10/08/202212h06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
10/08/202212h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:CRXTClarus Therapeutics Holdings Inc
09/08/202223h25Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRXTClarus Therapeutics Holdings Inc
28/07/202215h05GlobeNewswire Inc.Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)NASDAQ:CRXTClarus Therapeutics Holdings Inc
06/07/202222h00Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CRXTClarus Therapeutics Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:CRXT